Figure 4.
Aldosterone antagonist use. Association between aldosterone antagonist use and: (A) mortality and (B) hyperkalemia, in high‐risk subgroups. ACEI indicates angiotensin‐converting enzyme inhibitor; ARB, angiotensin receptor blocker; CI, confidence interval; CrCl, creatinine clearance; HR, hazard ratio; LVEF, left ventricular ejection fraction; MI, myocardial infarction; NSTEMI, non–ST‐segment elevation myocardial infarction; STEMI, ST‐segment elevation myocardial infarction.